{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T11:40:09Z","timestamp":1748086809635,"version":"3.41.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T00:00:00Z","timestamp":1748044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T00:00:00Z","timestamp":1748044800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-03088-3","type":"journal-article","created":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T11:15:36Z","timestamp":1748085336000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Psychometric properties of the Italian version of scale for outcomes in Parkinson\u2019s disease psychiatric complications in Parkinson disease"],"prefix":"10.1038","volume":"15","author":[{"given":"Sofia","family":"Cuoco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arianna","family":"Cappiello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Immacolata","family":"Carotenuto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Autuori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rossella","family":"Bisogno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristiano","family":"Sorrentino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Aiello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Barone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Picillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,24]]},"reference":[{"issue":"7","key":"3088_CR1","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1007\/s00415-004-0483-3","volume":"251","author":"A Schrag","year":"2004","unstructured":"Schrag, A. Psychiatric aspects of Parkinson\u2019s disease: An update. J. Neurol. 251(7), 795\u2013804. https:\/\/doi.org\/10.1007\/s00415-004-0483-3 (2004).","journal-title":"J. Neurol."},{"issue":"1","key":"3088_CR2","doi-asserted-by":"publisher","first-page":"65","DOI":"10.4103\/0976-3147.143197","volume":"6","author":"S Grover","year":"2015","unstructured":"Grover, S., Somaiya, M., Kumar, S. & Avasthi, A. Psychiatric aspects of Parkinson\u2019s disease. J. Neurosci. Rural Pract. 6(1), 65\u201376. https:\/\/doi.org\/10.4103\/0976-3147.143197 (2015).","journal-title":"J. Neurosci. Rural Pract."},{"issue":"9996","key":"3088_CR3","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia, L. V. & Lang, A. E. Parkinson\u2019s disease. Lancet 386(9996), 896\u2013912. https:\/\/doi.org\/10.1016\/S0140-6736(14)61393-3 (2015).","journal-title":"Lancet"},{"issue":"1","key":"3088_CR4","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s00415-006-0234-8","volume":"254","author":"D Aarsland","year":"2007","unstructured":"Aarsland, D. et al. The effect of age of onset of PD on risk of dementia. J. Neurol. 254(1), 38\u201345. https:\/\/doi.org\/10.1007\/s00415-006-0234-8 (2007).","journal-title":"J. Neurol."},{"issue":"8","key":"3088_CR5","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1136\/jnnp.2008.171231","volume":"80","author":"SE Starkstein","year":"2009","unstructured":"Starkstein, S. E. Neuropsychiatric disorders in early untreated Parkinson\u2019s disease. J. Neurol. Neurosurg. Psychiatry 80(8), 830. https:\/\/doi.org\/10.1136\/jnnp.2008.171231 (2009).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"7","key":"3088_CR6","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1002\/mds.22833","volume":"25","author":"NN Dissanayaka","year":"2010","unstructured":"Dissanayaka, N. N. et al. Anxiety disorders in Parkinson\u2019s disease: Prevalence and risk factors. Mov. Disord. 25(7), 838\u2013845. https:\/\/doi.org\/10.1002\/mds.22833 (2010).","journal-title":"Mov. Disord."},{"key":"3088_CR7","doi-asserted-by":"publisher","first-page":"1213393","DOI":"10.1155\/2022\/1213393","volume":"2022","author":"P Mac\u00edas-Garc\u00eda","year":"2022","unstructured":"Mac\u00edas-Garc\u00eda, P. et al. Neuropsychiatric symptoms in clinically defined Parkinson\u2019s disease: An updated review of literature. Behav. Neurol. 2022, 1213393. https:\/\/doi.org\/10.1155\/2022\/1213393 (2022).","journal-title":"Behav. Neurol."},{"issue":"11","key":"3088_CR8","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1002\/mds.22643","volume":"24","author":"P Barone","year":"2009","unstructured":"Barone, P. et al. The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson\u2019s disease. Mov. Disord. 24(11), 1641\u20131649. https:\/\/doi.org\/10.1002\/mds.22643 (2009).","journal-title":"Mov. Disord."},{"issue":"1","key":"3088_CR9","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S1474-4422(21)00330-6","volume":"21","author":"D Weintraub","year":"2022","unstructured":"Weintraub, D. et al. The neuropsychiatry of Parkinson;s disease: Advances and challenges. Lancet Neurol. 21(1), 89\u2013102. https:\/\/doi.org\/10.1016\/S1474-4422(21)00330-6 (2022).","journal-title":"Lancet Neurol."},{"issue":"7","key":"3088_CR10","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s00702-019-02019-7","volume":"126","author":"A Nagy","year":"2019","unstructured":"Nagy, A. & Schrag, A. Neuropsychiatric aspects of Parkinson\u2019s disease. J Neural Transm. (Vienna) 126(7), 889\u2013896. https:\/\/doi.org\/10.1007\/s00702-019-02019-7 (2019).","journal-title":"J Neural Transm. (Vienna)"},{"issue":"5","key":"3088_CR11","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1002\/mdc3.12968","volume":"7","author":"ALAJ Hommel","year":"2020","unstructured":"Hommel, A. L. A. J. et al. The prevalence and determinants of neuropsychiatric symptoms in late-stage parkinsonism. Mov. Disord. Clin. Pract. 7(5), 531\u2013542. https:\/\/doi.org\/10.1002\/mdc3.12968 (2020).","journal-title":"Mov. Disord. Clin. Pract."},{"key":"3088_CR12","doi-asserted-by":"publisher","first-page":"S105","DOI":"10.1016\/S1353-8020(09)70846-6","volume":"Suppl 4","author":"JM Rabey","year":"2009","unstructured":"Rabey, J. M. Hallucinations and psychosis in Parkinson\u2019s disease. Parkinsonism Relat. Disord. Suppl 4, S105\u2013S110. https:\/\/doi.org\/10.1016\/S1353-8020(09)70846-6 (2009).","journal-title":"Parkinsonism Relat. Disord."},{"issue":"4","key":"3088_CR13","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.jgg.2021.01.003","volume":"48","author":"J Zhong","year":"2021","unstructured":"Zhong, J. et al. Single-cell brain atlas of Parkinson\u2019s disease mouse model. J. Genet. Genom. 48(4), 277\u2013288. https:\/\/doi.org\/10.1016\/j.jgg.2021.01.003 (2021).","journal-title":"J. Genet. Genom."},{"issue":"1","key":"3088_CR14","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.cger.2019.09.004","volume":"36","author":"KJ Lizarraga","year":"2020","unstructured":"Lizarraga, K. J., Fox, S. H., Strafella, A. P. & Lang, A. E. Hallucinations, delusions and impulse control disorders in Parkinson disease. Clin. Geriatr. Med. 36(1), 105\u2013118. https:\/\/doi.org\/10.1016\/j.cger.2019.09.004 (2020).","journal-title":"Clin. Geriatr. Med."},{"issue":"1","key":"3088_CR15","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/mds.26432","volume":"31","author":"J Pagonabarraga","year":"2016","unstructured":"Pagonabarraga, J. et al. Minor hallucinations occur in drug-naive Parkinson\u2019s disease patients, even from the premotor phase. Mov. Disord. 31(1), 45\u201352. https:\/\/doi.org\/10.1002\/mds.26432 (2016).","journal-title":"Mov. Disord."},{"issue":"6","key":"3088_CR16","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1002\/mds.22839","volume":"25","author":"G F\u00e9nelon","year":"2010","unstructured":"F\u00e9nelon, G., Soulas, T., Zenasni, F. & Cleret de Langavant, L. The changing face of Parkinson\u2019s disease-associated psychosis: A cross-sectional study based on the new NINDS-NIMH criteria. Mov. Disord. 25(6), 763\u2013766. https:\/\/doi.org\/10.1002\/mds.22839 (2010).","journal-title":"Mov. Disord."},{"issue":"4","key":"3088_CR17","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1212\/wnl.45.4.669","volume":"45","author":"CG Goetz","year":"1995","unstructured":"Goetz, C. G. & Stebbins, G. T. Mortality and hallucinations in nursing home patients with advanced Parkinson\u2019s disease. Neurology 45(4), 669\u2013671. https:\/\/doi.org\/10.1212\/wnl.45.4.669 (1995).","journal-title":"Neurology"},{"issue":"Pt 9","key":"3088_CR18","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1093\/brain\/awp166","volume":"132","author":"F Manganelli","year":"2009","unstructured":"Manganelli, F. et al. Functional involvement of central cholinergic circuits and visual hallucinations in Parkinson\u2019s disease. Brain 132(Pt 9), 2350\u20132355 (2009).","journal-title":"Brain"},{"issue":"5","key":"3088_CR19","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1002\/gps.389","volume":"16","author":"D Aarsland","year":"2001","unstructured":"Aarsland, D., Ballard, C., Larsen, J. P. & McKeith, I. A comparative study of psychiatric symptoms in dementia with Lewy bodies and Parkinson\u2019s disease with and without dementia. Int. J. Geriatr. Psychiatry 16(5), 528\u2013536. https:\/\/doi.org\/10.1002\/gps.389 (2001).","journal-title":"Int. J. Geriatr. Psychiatry"},{"issue":"2","key":"3088_CR20","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1055\/s-2007-971168","volume":"27","author":"KM Biglan","year":"2007","unstructured":"Biglan, K. M. & Ravina, B. Neuroprotection in Parkinson\u2019s disease: An elusive goal. Semin. Neurol. 27(2), 106\u2013112. https:\/\/doi.org\/10.1055\/s-2007-971168 (2007).","journal-title":"Semin. Neurol."},{"issue":"5","key":"3088_CR21","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1001\/archneurol.2010.65","volume":"67","author":"D Weintraub","year":"2010","unstructured":"Weintraub, D. et al. Impulse control disorders in Parkinson disease: A cross-sectional study of 3090 patients. Arch. Neurol. 67(5), 589\u2013595. https:\/\/doi.org\/10.1001\/archneurol.2010.65 (2010).","journal-title":"Arch. Neurol."},{"issue":"4","key":"3088_CR22","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1007\/s00415-019-09692-4","volume":"267","author":"V Markovi\u0107","year":"2020","unstructured":"Markovi\u0107, V. et al. Dynamics of impulsive-compulsive behaviors in early Parkinson\u2019s disease: A prospective study. J. Neurol. 267(4), 1127\u20131136. https:\/\/doi.org\/10.1007\/s00415-019-09692-4 (2020).","journal-title":"J. Neurol."},{"issue":"15","key":"3088_CR23","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1002\/mds.21696","volume":"22","author":"M Visser","year":"2007","unstructured":"Visser, M. et al. Assessment of psychiatric complications in Parkinson\u2019s disease: The SCOPA-PC. Mov. Disord. 22(15), 2221\u20132228. https:\/\/doi.org\/10.1002\/mds.21696 (2007).","journal-title":"Mov. Disord."},{"issue":"1","key":"3088_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.33588\/rn.4901.2009014","volume":"49","author":"P Mart\u00ednez-Mart\u00edn","year":"2009","unstructured":"Mart\u00ednez-Mart\u00edn, P. et al. Atributos psicom\u00e9tricos de la Scales for Outcomes in Parkinson\u2019s Disease-Psychosocial (SCOPA-PS): validaci\u00f3n en Espa\u00f1a y revisi\u00f3n [Psychometric attributes of the Scales for Outcomes in Parkinson\u2019s Disease-Psychosocial (SCOPA-PS): validation in Spain and review]. Rev. Neurol. 49(1), 1\u20137 (2009).","journal-title":"Rev. Neurol."},{"issue":"1","key":"3088_CR25","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/mds.21216","volume":"22","author":"FJ Carod-Artal","year":"2007","unstructured":"Carod-Artal, F. J., Martinez-Martin, P. & Vargas, A. P. Independent validation of SCOPA-psychosocial and metric properties of the PDQ-39 Brazilian version. Mov. Disord. 22(1), 91\u201398. https:\/\/doi.org\/10.1002\/mds.21216 (2007).","journal-title":"Mov. Disord."},{"issue":"2","key":"3088_CR26","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1111\/j.1524-4733.2008.00436.x","volume":"12","author":"J Viru\u00e9s-Ortega","year":"2009","unstructured":"Viru\u00e9s-Ortega, J. et al. Cross-cultural validation of the scales for outcomes in Parkinson\u2019s disease-psychosocial questionnaire (SCOPA-PS) in four Latin American countries. Value Health 12(2), 385\u2013391. https:\/\/doi.org\/10.1111\/j.1524-4733.2008.00436.x (2009).","journal-title":"Value Health"},{"issue":"4\u20135","key":"3088_CR27","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.neurol.2015.10.010","volume":"172","author":"T Soulas","year":"2016","unstructured":"Soulas, T. et al. Assessing health-related quality of life with the SCOPA-PS in French individuals with Parkinson\u2019s disease having undergone DBS-STN: A validation study. Rev Neurol. (Paris) 172(4\u20135), 281\u2013288. https:\/\/doi.org\/10.1016\/j.neurol.2015.10.010 (2016).","journal-title":"Rev Neurol. (Paris)"},{"issue":"2","key":"3088_CR28","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/mdc3.12023","volume":"1","author":"CG Goetz","year":"2014","unstructured":"Goetz, C. G. et al. IPMDS-sponsored scale translation program: Process, Format, and clinimetric testing plan for the MDS-UPDRS and UDysRS. Mov. Disord. Clin. Pract. 1(2), 97\u2013101. https:\/\/doi.org\/10.1002\/mdc3.12023 (2014).","journal-title":"Mov. Disord. Clin. Pract."},{"issue":"12","key":"3088_CR29","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma, R. B. et al. MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov. Disord. 30(12), 1591\u20131601. https:\/\/doi.org\/10.1002\/mds.26424 (2015).","journal-title":"Mov. Disord."},{"key":"3088_CR30","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders 5th edn. (Author, 2013).","edition":"5"},{"issue":"2","key":"3088_CR31","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/mds.24023","volume":"27","author":"D Weintraub","year":"2012","unstructured":"Weintraub, D. et al. Questionnaire for impulsive-compulsive disorders in Parkinson\u2019s disease-rating scale. Mov. Disord. 27(2), 242\u2013247. https:\/\/doi.org\/10.1002\/mds.24023 (2012).","journal-title":"Mov. Disord."},{"issue":"4","key":"3088_CR32","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1001\/archneur.55.4.539","volume":"55","author":"G Binetti","year":"1998","unstructured":"Binetti, G. et al. Behavioral disorders in Alzheimer disease: A transcultural perspective. Arch. Neurol. 55(4), 539\u2013544. https:\/\/doi.org\/10.1001\/archneur.55.4.539 (1998).","journal-title":"Arch. Neurol."},{"issue":"4","key":"3088_CR33","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s00702-024-02746-6","volume":"131","author":"M Garon","year":"2024","unstructured":"Garon, M. et al. Validation of the Italian version of the Parkinson\u2019s disease: Cognitive functional rating scale. J. Neural Transm. 131(4), 305\u2013314. https:\/\/doi.org\/10.1007\/s00702-024-02746-6 (2024).","journal-title":"J. Neural Transm."},{"issue":"7","key":"3088_CR34","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1002\/mds.29410","volume":"38","author":"ST Jost","year":"2023","unstructured":"Jost, S. T. et al. Levodopa dose equivalency in Parkinson\u2019s disease: Updated systematic review and proposals. Mov. Disord. 38(7), 1236\u20131252 (2023).","journal-title":"Mov. Disord."},{"issue":"1","key":"3088_CR35","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3233\/JPD-160926","volume":"7","author":"G Bronner","year":"2017","unstructured":"Bronner, G., Hassin-Baer, S. & Gurevich, T. Sexual preoccupation behavior in parkinson\u2019s disease. J. Parkinsons Dis. 7(1), 175\u2013182. https:\/\/doi.org\/10.3233\/JPD-160926 (2017).","journal-title":"J. Parkinsons Dis."},{"issue":"4","key":"3088_CR36","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1002\/ana.20834","volume":"59","author":"JW Langston","year":"2006","unstructured":"Langston, J. W. The Parkinson\u2019s complex: Parkinsonism is just the tip of the iceberg. Ann. Neurol. 59(4), 591\u2013596. https:\/\/doi.org\/10.1002\/ana.20834 (2006).","journal-title":"Ann. Neurol."},{"issue":"4","key":"3088_CR37","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1002\/mds.21875","volume":"23","author":"HH Fernandez","year":"2008","unstructured":"Fernandez, H. H. et al. Scales to assess psychosis in Parkinson\u2019s disease: Critique and recommendations. Mov. Disord. 23(4), 484\u2013500. https:\/\/doi.org\/10.1002\/mds.21875 (2008).","journal-title":"Mov. Disord."},{"issue":"5","key":"3088_CR38","first-page":"280","volume":"21","author":"G Friedberg","year":"1998","unstructured":"Friedberg, G., Zoldan, J. & Weizman, A. Melamed, E- Parkinson psychosis rating scale: A practical instrument for grading psychosis in Parkinson\u2019s disease. Clin. Neuropharmacol. 21(5), 280\u2013284 (1998).","journal-title":"Clin. Neuropharmacol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-03088-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-03088-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-03088-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T11:15:36Z","timestamp":1748085336000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-03088-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,24]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3088"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-03088-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,24]]},"assertion":[{"value":"9 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests with the present work.\u00a0PB received consultancies as a member of the advisory board for Zambon, Lundbeck, UCB, Chiesi, Abbvie and Acorda. MP is supported by the Italian Ministry of Health and the Fondazione della Societ\u00e0 Italiana di Neurologia. The other authors report no financial disclosures.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The project was performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki. The Study Protocol was approved on 22.11.2023 by the Ethics Committee \u201cCampania 2\u201d, the protocol number is 166\/2021, All subjects agreed with a written consent form to the use of their anonymized data for research purposes, the study being approved by the local ethical committee. We confirm that we have read the Journal\u2019s position on issues involved in ethical publication and affirm that this work is consistent with those guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"18107"}}